healthcare

Can Editas Survive After Losing Its CEO?

Posted: January 22, 2019 at 1:00 pm

Editas Medicine Inc. (NASDAQ: EDIT) shares were crushed on Tuesday after the company announced that its president and chief executive, Katrine Bosley, would be stepping down from these roles effective ...
Read Full Story »

Johnson & Johnson Earnings: When Good Enough Just Isn’t Good Enough

Posted: January 22, 2019 at 8:30 am

Johnson & Johnson (NYSE: JNJ) released its fourth-quarter financial results before the markets opened on Tuesday. The health care giant said that it had in $1.97 earnings per share (EPS) ...
Read Full Story »

FDA Diabetes Treatment Vote to Determine the Fate of Lexicon Therapeutics?

Posted: January 18, 2019 at 11:06 am

Lexicon Pharmaceutics Inc. (NASDAQ: LXRX) shares fell on Friday after the U.S. Food and Drug Administration (FDA) voted to approve the firm’s type 1 diabetes treatment. Although the result from ...
Read Full Story »

Is Immunomedics Breast Cancer Treatment Doomed After This FDA Update?

Posted: January 18, 2019 at 9:50 am

Immunomedics Inc. (NASDAQ: IMMU) shares were crushed on Friday after the firm received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA). Usually, CRLs can spell ...
Read Full Story »

Is Spectrum Pharma Getting Enough for Its Hematology/Oncology Portfolio?

Posted: January 17, 2019 at 12:00 pm

Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI) shares made a handy gain early Thursday after the firm announced that it would be selling its portfolio of seven FDA-approved hematology/oncology products to Acrotech ...
Read Full Story »

Where Does Aptinyx Go Next After Disappointing Midstage Results for Pain Treatment?

Posted: January 16, 2019 at 11:50 am

Aptinyx Inc. (NASDAQ: APTX) shares were absolutely crushed on Wednesday after the firm reported midstage results from its clinical study in patients with painful diabetic peripheral neuropathy (DPN). Specifically, Aptinyx ...
Read Full Story »

Why CVS and Walmart Are Parting Ways

Posted: January 15, 2019 at 10:00 am

CVS Health Corp. (NYSE: CVS) has announced that it will be parting ways with megastore Walmart Inc. (NYSE: WMT). Specifically, Walmart has opted to leave the CVS Caremark pharmacy benefit management ...
Read Full Story »

Major Pharma Sees Fading Short Interest

Posted: January 11, 2019 at 9:50 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Biotechs Scare Off Short Sellers

Posted: January 11, 2019 at 8:25 am

The short interest data are out for the most recent settlement date, December 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Why the FDA Is Coming Down on Akorn

Posted: January 9, 2019 at 12:15 pm

Akorn Inc. (NASDAQ: AKRX) shares dipped on Wednesday after the company received a warning letter from the U.S. Food and Drug Administration (FDA). The letter is in relation to an ...
Read Full Story »

Analyst Names Top Legalized Marijuana Stocks for 2019

Posted: January 8, 2019 at 1:05 pm

The world of legalized marijuana and cannabis sales is expected to keep growing. A 2019 forecast report from Cowen now projects even stronger growth from this industry in the decade ...
Read Full Story »

Moderna Makes Big Post-IPO Strides With Pipeline Update

Posted: January 8, 2019 at 12:55 pm

Moderna Inc. (NASDAQ: MRNA) shares made a handy gain early Tuesday after the company announced updates to several of its immuno-oncology and rare disease programs and outlined its 2019–2020 corporate ...
Read Full Story »

Alector Files for IPO

Posted: January 8, 2019 at 8:55 am

Alector has filed its S-1 form with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO). No pricing details were given in the filing, although the ...
Read Full Story »

Are Loxo Shareholders Getting Enough in the Buyout?

Posted: January 7, 2019 at 11:05 am

Loxo Oncology Inc. (NASDAQ: LOXO) shares made a massive gain on Monday after it was announced that the firm would be acquired by Eli Lilly and Co. (NYSE: LLY). The ...
Read Full Story »

Why Axsome Therapeutics Depression Study Is All Smiles

Posted: January 7, 2019 at 11:00 am

Axsome Therapeutics Inc. (NASDAQ: AXSM) shares absolutely exploded on Monday after the company announced that its midstage trial in patients with major depressive disorder (MDD) met its primary endpoint. Not ...
Read Full Story »